AAAAAA

   
Results: 1-11 |
Results: 11
Melanoma differentiation associated gene-7 (mda-7): A novel anti-tumor gene for cancer gene therapy
Authors: Mhashilkar, AM Schrock, RD Hindi, M Liao, J Sieger, K Kourouma, F Zou-Yang, XH Onishi, E Takh, O Vedvick, TS Fanger, G Stewart, L Watson, GJ Snary, D Fisher, PB Saeki, T Roth, JA Ramesh, R Chada, S
Citation: Am. Mhashilkar et al., Melanoma differentiation associated gene-7 (mda-7): A novel anti-tumor gene for cancer gene therapy, MOL MED, 7(4), 2001, pp. 271-282
Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors
Authors: Wilkinson, RW Ross, EL Poulsom, R Ilyas, M Straub, J Snary, D Bodmer, WF Mather, SJ
Citation: Rw. Wilkinson et al., Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors, P NAS US, 98(18), 2001, pp. 10256-10260
Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores
Authors: Wilkinson, RW Lee-MacAry, AE Davies, D Snary, D Ross, EL
Citation: Rw. Wilkinson et al., Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores, J IMMUNOL M, 258(1-2), 2001, pp. 183-191
Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide
Authors: Lee-MacAry, AE Ross, EL Davies, D Laylor, R Honeychurch, J Glennie, MJ Snary, D Wilkinson, RW
Citation: Ae. Lee-macary et al., Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide, J IMMUNOL M, 252(1-2), 2001, pp. 83-92
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study
Authors: Andreyev, HJN Norman, AR Cunningham, D Oates, J Dix, BR Iacopetta, BJ Young, J Walsh, T Ward, R Hawkins, N Beranek, M Jandik, P Benamouzig, R Jullian, E Laurent-Puig, P Olschwang, S Muller, O Hoffmann, I Rabes, HM Zietz, C Troungos, C Valavanis, C Yuen, ST Ho, JWC Croke, CT O'Donoghue, DP Giaretti, W Rapallo, A Russo, A Bazan, V Tanaka, M Omura, K Azuma, T Ohkusa, T Fujimori, T Ono, Y Pauly, M Faber, C Glaesener, R de Goeij, AFPM Arends, JW Andersen, SN Lovig, T Breivik, J Gaudernack, G Clausen, OPF De Angelis, P Meling, GI Rognum, TO Smith, R Goh, HS Font, A Rosell, R Sun, XF Zhang, H Benhattar, J Losi, L Lee, JQ Wang, ST Clarke, PA Bell, S Quirke, P Bubb, VJ Piris, J Cruickshank, NR Morton, D Fox, JC Al-Mulla, F Lees, N Hall, CN Snary, D Wilkinson, K Dillon, D Costa, J Pricolo, VE Finkelstein, SD Thebo, JS Senagore, AJ Halter, SA Wadler, S Malik, S Krtolica, K Urosevic, N
Citation: Hjn. Andreyev et al., Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study, BR J CANC, 85(5), 2001, pp. 692-696
Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment
Authors: Paul, S Snary, D Hoebeke, J Allen, D Balloul, JM Bizouarne, N Dott, K Geist, M Hilgers, J Kieny, MP Burchell, J Papadimitriou, JT Acres, RB
Citation: S. Paul et al., Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment, HUM GENE TH, 11(10), 2000, pp. 1417-1428
A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1
Authors: Wilkinson, RW Ross, EL Lee-MacAry, AE Laylor, R Burchell, J Taylor-Papadimitriou, J Snary, D
Citation: Rw. Wilkinson et al., A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1, BR J CANC, 83(9), 2000, pp. 1202-1208
The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers
Authors: Hamilton, JA Stewart, LMD Ajayi, L Gray, IC Gray, NE Roberts, KG Watson, GJ Kaisary, AV Snary, D
Citation: Ja. Hamilton et al., The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers, BR J CANC, 82(10), 2000, pp. 1671-1676
Humanisation and characterisation of PR1A3, a monoclonal antibody specificfor cell-bound carcinoembryonic antigen
Authors: Stewart, LM Young, S Watson, G Mather, SJ Bates, PA Band, HA Wilkinson, RW Ross, EL Snary, D
Citation: Lm. Stewart et al., Humanisation and characterisation of PR1A3, a monoclonal antibody specificfor cell-bound carcinoembryonic antigen, CANCER IMMU, 47(6), 1999, pp. 299-306
A phase I/II trial of vaccination with a novel murine monoclonal anticarotid endarterectomy (CEA) antibody in patients with advanced colorectal cancer (vol 86, pg 102, 1999)
Authors: Zbar, AP Thomas, H Snary, D Wilkinson, RW Ross, EL Wadhwa, M Allen-Mersh, TG Kmiot, WA
Citation: Ap. Zbar et al., A phase I/II trial of vaccination with a novel murine monoclonal anticarotid endarterectomy (CEA) antibody in patients with advanced colorectal cancer (vol 86, pg 102, 1999), BR J SURG, 86(7), 1999, pp. 960-960
Crystal structure at 1.95 angstrom resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition
Authors: Dokurno, P Bates, PA Band, HA Stewart, LMD Lally, JM Burchell, JM Taylor-Papadimitriou, J Snary, D Sternberg, MJE Freemont, PS
Citation: P. Dokurno et al., Crystal structure at 1.95 angstrom resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition, J MOL BIOL, 284(3), 1998, pp. 713-728
Risultati: 1-11 |